Medical Equipment

Genomic And Proteomic Tool Market Trends 2025–2029: Forecasts for Key Growth Segments

November 21, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Genomic And Proteomic Tool Market Expected To Expand Between 2025 And 2029?

The genomic and proteomic tool market has seen rapid expansion in its market size during recent years. This market is projected to grow from $29.63 billion in 2024 to $33.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.8%. The historical growth can be attributed to the increasing incidence of cancer and rare diseases, the broadening of academic core laboratories, higher healthcare spending by high-income nations, the standardization of clinical guidelines for molecular testing, and more extensive reimbursement for molecular diagnostics.

The genomic and proteomic tool market size is projected to experience swift expansion over the coming years, reaching $51.20 billion by 2029, driven by an impressive compound annual growth rate (CAGR) of 11.5%. This growth during the forecast period is attributable to several factors, including an aging global population leading to a greater burden of chronic diseases, the incorporation of precision medicine into national health services, broadened payer coverage for biomarker testing, an increase in clinical trials that necessitate molecular stratification, and the increasing adoption of value-based care models that incentivize targeted therapies. Key trends anticipated within the forecast period encompass advancements in deoxyribonucleic acid long-read sequencing, enhanced throughput for single-cell ribonucleic acid sequencing, in-situ spatial co-detection of ribonucleic acid and proteins, the application of digital polymerase chain reaction for absolute quantification, and the use of trapped ion mobility spectrometry in proteomic analysis.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28235&type=smp

Which Drivers Are Supporting Growth Of The Genomic And Proteomic Tool Market?

The growing embrace of personalized medicine is anticipated to fuel the expansion of the genomic and proteomic tool market moving ahead. Personalized medicine involves customizing prevention, diagnosis, and treatment for each individual based on their unique molecular profile, utilizing biomarkers obtained from deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. This rising adoption stems from advancements in genomics, proteomics, and biomarker discovery, which facilitate customized treatments aligned with individual genetic profiles, thereby boosting demand for targeted therapies, enhanced diagnostics, and precise healthcare solutions. These advancements have specifically allowed for the creation of targeted treatments and more precise diagnostic methods, tailored to a patient’s genetic makeup. Genomic and proteomic tools are vital in this endeavor, helping to identify genetic variations and protein biomarkers, which empowers clinicians to refine treatments and achieve better patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, highlighted that the United States Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, a significant rise from just 6 approvals in 2022. Consequently, the expanding use of personalized medicine is propelling the genomic and proteomic tool market.

What Are The Primary Types Of Segments Analyzed In The Genomic And Proteomic Tool Market?

The genomic and proteomic tool market covered in this report is segmented as

1) By Product Type: Instruments, Consumables, Software, Services

By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography

3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting

4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research

5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers

Subsegments:

1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers

2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals

3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms

4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics Services

What Trends Are Expected To Drive The Genomic And Proteomic Tool Market?

Major companies operating in the genomic and proteomic tools market are focusing on innovation through spatial multi-omics technologies. These advancements enable same-cell, in-situ detection of RNA and proteins to integrate molecular data layers, preserve tissue architecture, and accelerate discovery. Spatial multi-omics entails measuring gene expression and protein markers simultaneously within intact tissue at single-cell or subcellular resolution, thereby offering richer biological insights than single-modality assays. For instance, in August 2025, 10x Genomics, a U.S.-based biotechnology company, introduced Xenium Protein, a first-of-its-kind assay for single-cell RNA and protein analysis on the Xenium in situ platform. This solution delivers a seamless, single-instrument workflow, eliminating the need for cross-platform data integration, and comes with validated, ready-to-use protein subpanels to simplify setup and quality control. These developments allow researchers to maintain spatial context while expanding biomarker panels for applications such as target validation, patient stratification, and mechanism-of-action studies.

Who Are The Prominent Global Companies Shaping The Genomic And Proteomic Tool Market?

Major companies operating in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., Sophia Genetics, LC Sciences.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genomic-and-proteomic-tool-global-market-report

What Are The Key Regional Factors Influencing The Genomic And Proteomic Tool Market Growth?

North America was the largest region in the genomic and proteomic tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in genomic and proteomic tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Genomic And Proteomic Tool Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28235&type=smp

Browse Through More Reports Similar to the Global Genomic And Proteomic Tool Market 2025, By The Business Research Company

Proteomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

Genomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genomics Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795